For the treatment of head and neck mucosal melanoma, compared with single immunotherapy, hypofractionation radiotherapy combined with PD-1 inhibitors can more effectively inhibit tumor growth and produce distant effects by activating the systemic CD8+T cell immune response. This evidence concerns the gene CD8A and neoplasm.